Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-24 @ 3:43 PM
NCT ID:
NCT03906292
Brief Title:
Frontline Asciminib Combination in Chronic Phase CML
Official Title:
Frontline Asciminib Combination in Chronic Phase CML
Acronym:
CMLXI
Study:
NCT03906292
Protocol Section:
NCT03906292